CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. (Q33867870)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

29 July 2017

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Ankur Goyal

1

1 reference

Europe PubMed Central

29 July 2017

P V Suneetha

2

1 reference

Europe PubMed Central

29 July 2017

G T Kumar

3

1 reference

Europe PubMed Central

29 July 2017

Deepak K Shukla

4

1 reference

Europe PubMed Central

29 July 2017

Naveen Arora

5

1 reference

Europe PubMed Central

29 July 2017

Shiv K Sarin

6

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

29 July 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

29 July 2017

12

1 reference

Europe PubMed Central

29 July 2017

29

1 reference

Europe PubMed Central

29 July 2017

4721-4726

1 reference

Europe PubMed Central

29 July 2017

The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

HLA association with hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Phenotypic expressions of CCR5-delta32/delta32 homozygosity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor-CCR5 gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Histopathology of hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

5 July 2018

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I29.4721

21 January 2018

Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

29 October 2018

HLA DR13 and HCV vertical infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087840

29 October 2018

Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CC chemokine receptor 5 polymorphism in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of rheumatoid arthritis with a functional chemokine receptor, CCR5

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V12.I29.4721

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33867870&oldid=1630765033"